ABSTRACT Background: Radioactive iodine-131 (RAI-131) is used for the treatment and
diagnosis of thyroid disorder. It is commonly used for internal radionuclide therapy of …

Introduction: Various amounts of the administered radioiodine dose in differentiated thyroid
treatment may expose unnecessary radiation to the inner organs. Hence, accurate …

Abstract Radioactive iodine (I-131) has been used for more than six decades for the
treatment of thyrotoxicosis. Radiation safety is of paramount importance in I-131 based …

Background: Iodine-131 NaI is the mainstay of treatment in patients with well differentiated
carcinoma. Fixed versus dosimetrically determined doses for iodine therapy are long in …

Background: In medical applications of radioisotopes, for calculations of whole body doses
and radiation safety applications, there is a need to estimate radioactive body burden. Local …

Introduction: In patients with thyroid carcinoma, radiation ABSORBED DOSE s of the thyroid
and surrounding tissues is important to weigh risk and benefit considerations. In nuclear …

[en] The uptake of radio iodine in different organs of the thyroid cancer patients has been
quantified to determine the absorbed doses and subsequent effective dose equivalent using …

Background: Radiation workers have reported that some errors during measurement of
radioiodine-131 activities have been observed, which may result poor quality images …

Background: Radiation absorbed dose to the red bone marrow, in the therapy of
differentiated thyroid carcinoma (DTC) with 131I (radioiodine), cannot be measured directly …

Introduction: Retention of I-131 in the body of patients with differentiated thyroid carcinoma
(DTC) has a direct effect on therapeutic outcome of radioiodine therapy. There are several …